Interleukin-13 receptor subunit alpha-2 (IL-13Rα2), also known as CD213A2 (cluster of differentiation 213A2), is a membrane bound protein that in humans is encoded by the IL13RA2gene.[1]
IL-13Rα2 is closely related to IL-13Rα1, a subunit of the interleukin-13 receptor complex. This protein binds IL13 with high affinity, but lacks any significant cytoplasmic domain, and does not appear to function as a signal mediator. It is, however, able to regulate the effects of both IL-13 and IL-4, despite the fact it is unable to bind directly to the latter. It is also reported to play a role in the internalization of IL13.[1]
Andrews AL, Nasir T, Bucchieri F, et al. (1996). "IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts". J. Allergy Clin. Immunol. 118 (4): 858–65. doi:10.1016/j.jaci.2006.06.041. PMID17030238.
Caput D, Laurent P, Kaghad M, et al. (1996). "Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain". J. Biol. Chem. 271 (28): 16921–6. doi:10.1074/jbc.271.28.16921. PMID8663118.
Zhang JG, Hilton DJ, Willson TA, et al. (1997). "Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains". J. Biol. Chem. 272 (14): 9474–80. doi:10.1074/jbc.272.14.9474. PMID9083087.
Gauchat JF, Schlagenhauf E, Feng NP, et al. (1997). "A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor". Eur. J. Immunol. 27 (4): 971–8. doi:10.1002/eji.1830270425. PMID9130652.
Guo J, Apiou F, Mellerin MP, et al. (1997). "Chromosome mapping and expression of the human interleukin-13 receptor". Genomics. 42 (1): 141–5. doi:10.1006/geno.1997.4628. PMID9177784.
Donaldson DD, Whitters MJ, Fitz LJ, et al. (1998). "The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1". J. Immunol. 161 (5): 2317–24. PMID9725226.
Osawa M, Miyoshi S, Copeland NG, et al. (2000). "Characterization of the mouse interleukin-13 receptor alpha1 gene". Immunogenetics. 51 (11): 974–81. doi:10.1007/s002510000225. PMID11003391.
Kawakami K, Takeshita F, Puri RK (2001). "Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain". J. Biol. Chem. 276 (27): 25114–20. doi:10.1074/jbc.M100936200. PMID11352909.
Daines MO, Hershey GK (2002). "A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma". J. Biol. Chem. 277 (12): 10387–93. doi:10.1074/jbc.M108109200. PMID11786536.
Okano F, Storkus WJ, Chambers WH, et al. (2002). "Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain". Clin. Cancer Res. 8 (9): 2851–5. PMID12231526.
Cancino-Díaz JC, Reyes-Maldonado E, Bañuelos-Pánuco CA, et al. (2003). "Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein". J. Invest. Dermatol. 119 (5): 1114–20. doi:10.1046/j.1523-1747.2002.19509.x. PMID12445201.
Arima K, Sato K, Tanaka G, et al. (2005). "Characterization of the interaction between interleukin-13 and interleukin-13 receptors". J. Biol. Chem. 280 (26): 24915–22. doi:10.1074/jbc.M502571200. PMID15870068.
Fichtner-Feigl S, Strober W, Kawakami K, et al. (2006). "IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis". Nat. Med. 12 (1): 99–106. doi:10.1038/nm1332. PMID16327802.
Daines MO, Tabata Y, Walker BA, et al. (2006). "Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling". J. Immunol. 176 (12): 7495–501. doi:10.4049/jimmunol.176.12.7495. PMID16751396.
Kioi M, Kawakami M, Shimamura T, et al. (2006). "Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy". Cancer. 107 (6): 1407–18. doi:10.1002/cncr.22134. PMID16902988.
Granel B, Allanore Y, Chevillard C, et al. (2007). "IL13RA2 gene polymorphisms are associated with systemic sclerosis". J. Rheumatol. 33 (10): 2015–9. PMID16981293.